[{"Assets_0_Q1_USD":149239000.0,"CommonStockSharesOutstanding_0_Q1_shares":21163590.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-15138000.0,"NetIncomeLoss_1_Q1_USD":-7661000.0,"StockholdersEquity_0_Q1_USD":114621000.0,"Ticker":"PTGX","CIK":"1377121","name":"PROTAGONIST THERAPEUTICS, INC","OfficialName":"Protagonist Therapeutics Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"939483174.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180509"}]